Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Drug Resistance

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 338 articles:
HTML format



Single Articles


    May 2020
  1. SILVA V, Miranda C, Antao HS, Guimaraes J, et al
    Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis.
    Int J Antimicrob Agents. 2020 May 18:106021.
    PubMed     Abstract available


  2. JEAN SS, Ko WC, Hsueh PR
    Susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum beta-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from the Antimicrobial Testing Leadership and Surv
    Int J Antimicrob Agents. 2020 May 15:106016.
    PubMed     Abstract available


  3. BODENDOERFER E, Marchesi M, Imkamp F, Courvalin P, et al
    Co-occurrence of aminoglycoside and beta-lactam resistance mechanisms in aminoglycoside- non-susceptible Escherichia coli isolated in the Zurich area, Switzerland.
    Int J Antimicrob Agents. 2020 May 15:106019.
    PubMed     Abstract available


  4. CASTANHEIRA M, Doyle TB, Hubler C, Sader HS, et al
    Ceftazidime-Avibactam Activity against a Challenge Set of Carbapenem-Resistant Enterobacterales: Ompk36 L3 Alterations and beta-Lactamases with Ceftazidime Hydrolytic Activity Lead to Elevated MIC Values.
    Int J Antimicrob Agents. 2020 May 14:106011.
    PubMed     Abstract available


  5. ARCAY RM, Suarez-Bode L, Lopez-Causape C, Oliver A, et al
    Corrigendum to ``Emergence of high level and stable metronidazole resistance in Clostridioides difficile'' [International Journal of Antimicrobial Agents Vol. 55 (2020) 5830].
    Int J Antimicrob Agents. 2020 May 4:105991.
    PubMed    


    April 2020
  6. CHENG JW, Liu C, Kudinha T, Xiao M, et al
    The tcdA negative and tcdB positive Clostridium difficile ST81 clone exhibits high-level fluoroquinolone resistance: a multi-center study in Beijing, China.
    Int J Antimicrob Agents. 2020 Apr 21:105981.
    PubMed     Abstract available


  7. VINUE L, Sater MRA, Herriott IC, Huntley MH, et al
    Plasmids and genes contributing to high-level quinolone resistance in Escherichia coli.
    Int J Antimicrob Agents. 2020 Apr 21:105987.
    PubMed     Abstract available


  8. KRESKEN M, Korber-Irrgang B, Korte-Berwanger M, Pfennigwerth N, et al
    Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
    Int J Antimicrob Agents. 2020 Apr 20:105959.
    PubMed     Abstract available


    March 2020
  9. MOUNA H, Stylianos C, Linda H, Efthimia P, et al
    Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: a nationwide study from 2014 to 2017: Carbapenem and colistin resistant Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2020 Mar 1:105930.
    PubMed     Abstract available


  10. GANDRA S, Choi J, McElvania E, Green SJ, et al
    Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    Int J Antimicrob Agents. 2020;55:105902.
    PubMed     Abstract available


  11. NAHA S, Sands K, Mukherjee S, Roy C, et al
    KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: Clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump.
    Int J Antimicrob Agents. 2020;55:105903.
    PubMed     Abstract available


  12. GALIZZI N, Poli A, Galli L, Muccini C, et al
    Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients.
    Int J Antimicrob Agents. 2020;55:105893.
    PubMed     Abstract available


  13. KIZHAKKEKALAM VK, Chakraborty K, Joy M
    Oxygenated elansolid-type of polyketide spanned macrolides from a marine heterotrophic Bacillus as prospective antimicrobial agents against multidrug-resistant pathogens.
    Int J Antimicrob Agents. 2020;55:105892.
    PubMed     Abstract available


  14. GARCIA-FERNANDEZ S, Garcia-Castillo M, Melo-Cristino J, Pinto MF, et al
    In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study.
    Int J Antimicrob Agents. 2020;55:105887.
    PubMed     Abstract available


  15. CHIEN HT, Lin YC, Sheu CC, Hsieh KP, et al
    Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.
    Int J Antimicrob Agents. 2020;55:105889.
    PubMed     Abstract available


  16. MARAOLO AE, Mazzitelli M, Trecarichi EM, Buonomo AR, et al
    Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications.
    Int J Antimicrob Agents. 2020;55:105891.
    PubMed     Abstract available


  17. ABDELRAOUF K, Chavda KD, Satlin MJ, Jenkins SG, et al
    Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance.
    Int J Antimicrob Agents. 2020;55:105885.
    PubMed     Abstract available


  18. YANG TY, Wang SF, Lin JE, Griffith BTS, et al
    Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2020;55:105894.
    PubMed     Abstract available


  19. OROFINO F, Truglio GI, Fiorucci D, D'Agostino I, et al
    In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.
    Int J Antimicrob Agents. 2020;55:105865.
    PubMed     Abstract available


  20. GERSON S, Lucassen K, Wille J, Nodari CS, et al
    Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2020;55:105862.
    PubMed     Abstract available


  21. JIA X, Ma W, He J, Tian X, et al
    Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia.
    Int J Antimicrob Agents. 2020;55:105832.
    PubMed     Abstract available


    February 2020
  22. BONNIN RA, Bernabeu S, Jaureguy F, Naas T, et al
    MCR-8 mediated colistin resistance in a carbapenem-resistant Klebsiella pneumoniae isolated from a repatriated patient from Morocco.
    Int J Antimicrob Agents. 2020 Feb 13:105920.
    PubMed    


    January 2020
  23. TSAI YK, Liou CH, Lin JC, Fung CP, et al
    Effects of different mechanisms on antimicrobial resistance in Acinetobacter baumannii: A strategic system for the screening and activity testing of new antibiotics.
    Int J Antimicrob Agents. 2020 Jan 30:105918.
    PubMed     Abstract available


  24. CEBALLOS S, Aspiroz C, Ruiz-Ripa L, Zarazaga M, et al
    Antimicrobial resistance phenotypes and genotypes of methicillin-resistant Staphylococcus aureus CC398 isolates from Spanish hospitals.
    Int J Antimicrob Agents. 2020 Jan 25:105907.
    PubMed     Abstract available


  25. VAN DER SCHALK TE, Braam JF, Kusters JG
    Molecular Basis of Antibiotic Resistance in Mycoplasma genitalium.
    Int J Antimicrob Agents. 2020 Jan 25:105911.
    PubMed     Abstract available


  26. DA SILVA BNM, Faria AR, de Souza SDSR, Colodette SS, et al
    Expression of VanA-type vancomycin resistance in a clinical isolate of Enterococcus faecium showing insertion of IS19 in the vanS gene.
    Int J Antimicrob Agents. 2020 Jan 10:105897.
    PubMed     Abstract available


  27. BRITT NS, Hazlett DS, Horvat RT, Liesman RM, et al
    Activity of Pulmonary Vancomycin Exposures versus Planktonic and Biofilm Methicillin-Resistant Staphylococcus aureus Isolated from Cystic Fibrosis Sputum.
    Int J Antimicrob Agents. 2020 Jan 10:105898.
    PubMed     Abstract available


  28. BOCHAROVA Y, Savinova T, Lazareva A, Polikarpova S, et al
    Genotypes, carbapenemase carriage, integron diversity, and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Int J Antimicrob Agents. 2020 Jan 10:105899.
    PubMed     Abstract available


  29. TUMBARELLO M, Raffaelli F, Peghin M, Losito AR, et al
    Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.
    Int J Antimicrob Agents. 2020 Jan 10:105900.
    PubMed     Abstract available


  30. LAU CH, DeJong EN, Dussault F, Carrillo C, et al
    A penicillin-binding protein that can promote advanced-generation cephalosporin resistance and genome adaptation in the opportunistic pathogen Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2020 Jan 9:105896.
    PubMed     Abstract available


    December 2019
  31. YONEDA A, Thanert R, Burnham CD, Dantas G, et al
    In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Int J Antimicrob Agents. 2019 Dec 20:105864.
    PubMed     Abstract available


  32. GARIMELLA N, Zere T, Hartman N, Gandhi A, et al
    The Effect of Drug Combinations on the Kinetics of the Emergence of Antibiotic Resistance in E. coli CFT073 Using the In Vitro Hollow Fiber Infection Model.
    Int J Antimicrob Agents. 2019 Dec 12:105861.
    PubMed     Abstract available


    November 2019
  33. SHAMINA OV, Kryzhanovskaya OA, Lazareva AV, Alyabieva NM, et al
    Emergence of the ST307 clone carrying a novel insertion element MITEKpn1 in the mgrB gene among carbapenem-resistant Klebsiella pneumoniae from Moscow, Russia.
    Int J Antimicrob Agents. 2019 Nov 23. pii: S0924-8579(19)30321.
    PubMed     Abstract available


  34. BORJAN J, Meyer KA, Shields RK, Wenzler E, et al
    Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
    Int J Antimicrob Agents. 2019 Nov 23. pii: S0924-8579(19)30323.
    PubMed     Abstract available


  35. LONGO LGA, de Sousa VS, Kraychete GB, Justo-da-Silva LH, et al
    Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
    Int J Antimicrob Agents. 2019;54:579-586.
    PubMed     Abstract available


  36. BERBEL D, Camara J, Garcia E, Tubau F, et al
    A novel genomic island harbouring lsa(E) and lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics.
    Int J Antimicrob Agents. 2019;54:647-651.
    PubMed     Abstract available


  37. RODRIGUEZ CH, Traglia G, Bastias N, Pandolfo C, et al
    Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Int J Antimicrob Agents. 2019;54:587-591.
    PubMed     Abstract available


  38. YANG LL, Li Q, Zhou LB, Chen SQ, et al
    Meta-analysis and systematic review of the efficacy and resistance for human immunodeficiency virus type 1 integrase strand transfer inhibitors.
    Int J Antimicrob Agents. 2019;54:547-555.
    PubMed     Abstract available


  39. HU Y, He W, Yao D, Dai H, et al
    Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug-resistant Gram-negative bacteria: A systematic review and meta-analysis.
    Int J Antimicrob Agents. 2019;54:556-561.
    PubMed     Abstract available


  40. NOEL AR, Attwood M, Bowker KE, Kim A, et al
    Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.
    Int J Antimicrob Agents. 2019;54:626-632.
    PubMed     Abstract available


    October 2019
  41. AGYEMAN AA, Bergen PJ, Rao GG, Nation RL, et al
    A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.
    Int J Antimicrob Agents. 2019 Oct 30. pii: S0924-8579(19)30294.
    PubMed     Abstract available


  42. ABUTALEB NS, Seleem MN
    Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies.
    Int J Antimicrob Agents. 2019 Oct 26. pii: S0924-8579(19)30289.
    PubMed     Abstract available


  43. ARCAY RM, Suarez L, Causape CL, Oliver A, et al
    Emergence of high level and stable metronidazole resistance in Clostridioides difficile.
    Int J Antimicrob Agents. 2019 Oct 26. pii: S0924-8579(19)30291.
    PubMed    


  44. SEIFERT H, Stefanik D, Olesky M, Higgins PG, et al
    In-vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2019 Oct 26. pii: S0924-8579(19)30290.
    PubMed     Abstract available


  45. GREBER KE, Roch M, Rosato MA, Martinez MP, et al
    Efficacy of newly generated short antimicrobial cationic lipopeptides against methicillin-resistant Staphylococcus aureus (MRSA).
    Int J Antimicrob Agents. 2019 Oct 18. pii: S0924-8579(19)30282.
    PubMed     Abstract available


  46. DHAOUADI S, Soufi L, Campanile F, Dhaouadi F, et al
    Prevalence of methicillin-resistant and susceptible coagulase-negative staphylococci with the first detection of the mecC gene among cows, humans, and manure in Tunisia.
    Int J Antimicrob Agents. 2019 Oct 18. pii: S0924-8579(19)30281.
    PubMed     Abstract available


  47. CHEN CH, Huang CL, He MS, Huang FC, et al
    Characterization of the beta-lactam-resistant enzyme in Acanthamoeba castellanii.
    Int J Antimicrob Agents. 2019 Oct 14. pii: S0924-8579(19)30278.
    PubMed     Abstract available


  48. WU D, Yan B, Yang X, Ji S, et al
    Whole-genome sequencing for the detection of linezolid resistance in a patient with persistent methicillin-resistant Staphylococcus aureus infection during linezolid exposure.
    Int J Antimicrob Agents. 2019 Oct 7. pii: S0924-8579(19)30274.
    PubMed    


  49. MALCHIONE MD, Torres LM, Hartley DM, Koch M, et al
    Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
    Int J Antimicrob Agents. 2019;54:381-399.
    PubMed     Abstract available


  50. AYERBE-ALGABA R, Gil-Marques ML, Miro-Canturri A, Parra-Millan R, et al
    The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
    Int J Antimicrob Agents. 2019;54:507-512.
    PubMed     Abstract available


    September 2019
  51. LIU Y, Han C, Chen Z, Guo D, et al
    Relationship between livestock exposure and methicillin-resistant Staphylococcus aureus carriage in humans: A systematic review and dose-response meta-analysis.
    Int J Antimicrob Agents. 2019 Sep 20. pii: S0924-8579(19)30257.
    PubMed     Abstract available


  52. BARRAUD O, Ravry C, Francois B, Daix T, et al
    Shotgun metagenomics for microbiome and resistome detection in septic patients with urinary tract infections.
    Int J Antimicrob Agents. 2019 Sep 16. pii: S0924-8579(19)30252.
    PubMed     Abstract available


  53. ORTEGA-HUEDO R, Cuesta M, Hoefer A, Gonzalez-Zorn B, et al
    Setting up econometric ARIMA methodology to elucidate European Union nosocomial antimicrobial resistance rate trend evolution based on largest EU database.
    Int J Antimicrob Agents. 2019 Sep 12. pii: S0924-8579(19)30247.
    PubMed     Abstract available


  54. BARROS J, Melo LDR, Poeta P, Igrejas G, et al
    Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Int J Antimicrob Agents. 2019;54:329-337.
    PubMed     Abstract available


    August 2019
  55. YIN Y, Chen H, Li S, Gao H, et al
    Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
    Int J Antimicrob Agents. 2019 Aug 31. pii: S0924-8579(19)30239.
    PubMed     Abstract available


  56. MURPHY RJ, Ramsay JP, Lee YT, Pang S, et al
    Multiple introductions of methicillin-resistant Staphylococcus aureus ST612 into Western Australia associated with both human and equine reservoirs.
    Int J Antimicrob Agents. 2019 Aug 31. pii: S0924-8579(19)30240.
    PubMed     Abstract available


  57. ONORATO L, Caprio GD, Signoriello S, Coppola N, et al
    EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS.
    Int J Antimicrob Agents. 2019 Aug 31. pii: S0924-8579(19)30243.
    PubMed     Abstract available


  58. MULOI D, Kiiru J, Ward MJ, Hassell JM, et al
    Epidemiology of antimicrobial resistant Escherichia coli carriage in sympatric humans and livestock in a rapidly urbanising city.
    Int J Antimicrob Agents. 2019 Aug 19. pii: S0924-8579(19)30225.
    PubMed     Abstract available


  59. QIN X, Zhao Y, Chen W, Wu X, et al
    Changing of antibiotic susceptibility and molecular characterization of Neisseria gonorrhoeae isolates in Guangdong, China:in a background of rapidly raising epidemic.
    Int J Antimicrob Agents. 2019 Aug 16. pii: S0924-8579(19)30226.
    PubMed     Abstract available


  60. MACHUCA I, Gutierrez-Gutierrez B, Rivera-Espinar F, Cano A, et al
    External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance.
    Int J Antimicrob Agents. 2019 Aug 1. pii: S0924-8579(19)30206.
    PubMed     Abstract available


  61. XU Q, Jiang J, Zhu Z, Xu T, et al
    Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.
    Int J Antimicrob Agents. 2019;54:223-227.
    PubMed     Abstract available


  62. NADIMPALLI ML, de Lauzanne A, Phe T, Borand L, et al
    Escherichia coli ST410 among humans and the environment in Southeast Asia.
    Int J Antimicrob Agents. 2019;54:228-232.
    PubMed     Abstract available


  63. SEO MR, Kim B, Kim J, Pai H, et al
    Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
    Int J Antimicrob Agents. 2019;54:154-158.
    PubMed     Abstract available


  64. GOULD M, Ginn AN, Marriott D, Norris R, et al
    Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae.
    Int J Antimicrob Agents. 2019;54:240-244.
    PubMed     Abstract available


  65. SCHAUMBURG F, Bletz S, Mellmann A, Becker K, et al
    Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.
    Int J Antimicrob Agents. 2019;54:255-260.
    PubMed     Abstract available


    July 2019
  66. NIBBERING PH, Goblyos A, Adriaans AE, Cordfunke RA, et al
    Eradication of methicillin resistant S. aureus from human skin by the novel LL-37-derived peptide P10 in four pharmaceutical ointments.
    Int J Antimicrob Agents. 2019 Jul 26. pii: S0924-8579(19)30194.
    PubMed     Abstract available


  67. ZHANG L, Zhai W, Lin Q, Zhu X, et al
    Carbapenem-resistant Enterobacteriaceae in hematological patients: outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization.
    Int J Antimicrob Agents. 2019 Jul 3. pii: S0924-8579(19)30176.
    PubMed    


  68. MASTERTON RG, Bassetti M, Chastre J, MacDonald AG, et al
    Valuing antibiotics: The role of the hospital clinician.
    Int J Antimicrob Agents. 2019;54:16-22.
    PubMed     Abstract available


  69. HMEDE Z, Sulaiman AAA, Jaafar H, Kassem II, et al
    Emergence of plasmid-borne colistin resistance gene mcr-1 in multidrug-resistant Escherichia coli isolated from irrigation water in Lebanon.
    Int J Antimicrob Agents. 2019;54:102-104.
    PubMed    


  70. LIU BT, Li X, Zhang Q, Shan H, et al
    Colistin-Resistant mcr-Positive Enterobacteriaceae in Fresh Vegetables, an Increasing Infectious Threat in China.
    Int J Antimicrob Agents. 2019;54:89-94.
    PubMed     Abstract available


  71. TACCONELLI E, Cataldo MA, Mutters NT, Carrara E, et al
    Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections.
    Int J Antimicrob Agents. 2019;54:49-54.
    PubMed     Abstract available


  72. HUANG J, Sun J, Wu Y, Chen L, et al
    Identification and pathogenicity of an XDR Streptococcus suis isolate that harbours the phenicol-oxazolidinone resistance genes optrA and cfr, and the bacitracin resistance locus bcrABDR.
    Int J Antimicrob Agents. 2019;54:43-48.
    PubMed     Abstract available


  73. ZHANG G, Sun K, Ai G, Li J, et al
    A novel family of intrinsic chloramphenicol acetyltransferase CATC in Vibrio parahaemolyticus: Naturally occurring variants reveal diverse resistance levels against chloramphenicol.
    Int J Antimicrob Agents. 2019;54:75-79.
    PubMed     Abstract available


  74. LU X, Xiao X, Liu Y, Li Y, et al
    Chromosome-mediated mcr-1 in Escherichia coli strain L73 from a goose.
    Int J Antimicrob Agents. 2019;54:99-101.
    PubMed    


    June 2019
  75. LEE YL, Lu MC, Shao PL, Lu PL, et al
    Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30162.
    PubMed     Abstract available


  76. SMOKE S, Raja K, Narayanan N, Brunetti L, et al
    Selective Antibiotic Susceptibility Reporting and Broad-Spectrum Intravenous Antibiotic Use: a Multicenter Ecological Study.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30164.
    PubMed     Abstract available


  77. VAN DER WEIDE H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, et al
    Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    Int J Antimicrob Agents. 2019 Jun 4. pii: S0924-8579(19)30136.
    PubMed     Abstract available


  78. JANGRA M, Kaur M, Nandanwar H
    In-vitro studies on a natural lantibiotic, paenibacillin: A new-generation antibacterial drug candidate to overcome multi-drug resistance.
    Int J Antimicrob Agents. 2019;53:838-843.
    PubMed     Abstract available


  79. MURRAY AK, Zhang L, Snape J, Gaze WH, et al
    Comparing the selective and co-selective effects of different antimicrobials in bacterial communities.
    Int J Antimicrob Agents. 2019;53:767-773.
    PubMed     Abstract available


  80. FALAGAS ME, Voulgaris GL, Tryfinopoulou K, Giakkoupi P, et al
    Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.
    Int J Antimicrob Agents. 2019;53:855-858.
    PubMed     Abstract available


  81. MOHD SAZLLY LIM S, Sime FB, Roberts JA
    Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation.
    Int J Antimicrob Agents. 2019;53:726-745.
    PubMed     Abstract available


  82. ZAMUDIO R, Hijazi K, Joshi C, Aitken E, et al
    Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Int J Antimicrob Agents. 2019;53:774-780.
    PubMed     Abstract available


  83. ZHANG Y, Zhao Y, Xu C, Zhang X, et al
    Chlorhexidine exposure of clinical Klebsiella pneumoniae strains leads to acquired resistance to this disinfectant and to colistin.
    Int J Antimicrob Agents. 2019;53:864-867.
    PubMed     Abstract available


  84. LI H, Wang Y, Meng Q, Wang Y, et al
    Comprehensive proteomic and metabolomic profiling of mcr-1-mediated colistin resistance in Escherichia coli.
    Int J Antimicrob Agents. 2019;53:795-804.
    PubMed     Abstract available


  85. RAOULT D, Rolain JM
    The living croquet theory: The Staphylococcus aureus paradigm.
    Int J Antimicrob Agents. 2019;53:724-725.
    PubMed    


    May 2019
  86. HAFFLER ZJ, Kulengowski B, Ribes JA, Burgess DS, et al
    Evaluation of the BD Phoenix(TM) automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared to broth microdilution.
    Int J Antimicrob Agents. 2019 May 6. pii: S0924-8579(19)30109.
    PubMed     Abstract available


  87. THOMAS VM, Brown RM, Ashcraft DS, Pankey GA, et al
    Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2019;53:663-668.
    PubMed     Abstract available


  88. BARRAUD O, Laurent F, Dyon-Tafani V, Dupieux-Chabert C, et al
    Novel staphylococcal cassette chromosome composite island (SCC-CI) with a new subtype of SCCmecVI cassette found in ST5 methicillin-resistant Staphylococcus aureus in France.
    Int J Antimicrob Agents. 2019;53:694-697.
    PubMed     Abstract available


  89. BINDER J, Held J, Krappmann S
    Impairing fluoride export of Aspergillus fumigatus mitigates its voriconazole resistance.
    Int J Antimicrob Agents. 2019;53:689-693.
    PubMed     Abstract available


  90. POTRON A, Bour M, Triponney P, Muller J, et al
    Sequential emergence of colistin and rifampicin resistance in an OXA-72- producing outbreak strain of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2019;53:669-673.
    PubMed     Abstract available


  91. GOMEZ-JUNYENT J, Benavent E, Sierra Y, El Haj C, et al
    Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Int J Antimicrob Agents. 2019;53:612-619.
    PubMed     Abstract available


  92. CLARK ST, Sinha U, Zhang Y, Wang PW, et al
    Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with beta-lactams.
    Int J Antimicrob Agents. 2019;53:620-628.
    PubMed     Abstract available


  93. LI W, Hou M, Liu C, Xiong W, et al
    Dramatic decrease in colistin resistance in Escherichia coli from a typical pig farm following restriction of colistin use in China.
    Int J Antimicrob Agents. 2019;53:707-708.
    PubMed    


  94. TANG HJ, Lai CC, Lai FJ, Li SY, et al
    Emergence of multidrug-resistant Candida auris in Taiwan.
    Int J Antimicrob Agents. 2019;53:705-706.
    PubMed    


  95. PARVEZ S, Misba L, Ahmad QT, Khan AU, et al
    Emergence of Extremely Drug-Resistant and Uropathogenic New Delhi Metallo-beta-Lactamse-6 (blaNDM-6)-producing Citrobacter werkmanii.
    Int J Antimicrob Agents. 2019;53:703-704.
    PubMed    


    April 2019
  96. BHATTACHARJEE B, Bardhan T, Chakraborty M, Basu M, et al
    Resistance profiles and resistome mapping of multidrug resistant carbapenem-hydrolyzing Klebsiella pneumoniae strains isolated from the nares of preterm neonates.
    Int J Antimicrob Agents. 2019;53:535-537.
    PubMed    


  97. DOSSIM S, Bonnin RA, Salou M, Tanga K, et al
    Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa.
    Int J Antimicrob Agents. 2019;53:530-532.
    PubMed    


  98. STERRANTINO G, Borghi V, Callegaro AP, Bruzzone B, et al
    Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors.
    Int J Antimicrob Agents. 2019;53:515-519.
    PubMed     Abstract available


  99. TRAGLIA GM, Place K, Dotto C, Fernandez JS, et al
    Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain.
    Int J Antimicrob Agents. 2019;53:483-490.
    PubMed     Abstract available


  100. ZENG S, Meng X, Huang Q, Lei N, et al
    Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
    Int J Antimicrob Agents. 2019;53:362-369.
    PubMed     Abstract available


  101. LUNA BL, Garcia JA, Huang M, Ewing PJ, et al
    Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
    Int J Antimicrob Agents. 2019;53:474-482.
    PubMed     Abstract available


  102. PIEWNGAM P, Quinones M, Thirakittiwatthana W, Yungyuen T, et al
    Composition of the intestinal microbiota in extended-spectrum beta-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Int J Antimicrob Agents. 2019;53:435-441.
    PubMed     Abstract available


  103. ABBARA S, Pitsch A, Jochmans S, Hodjat K, et al
    Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Int J Antimicrob Agents. 2019;53:416-422.
    PubMed     Abstract available


  104. COUVE-DEACON E, Jove T, Afouda P, Barraud O, et al
    Class 1 integrons in Acinetobacter baumannii: a weak expression of gene cassettes to counterbalance the lack of LexA-driven integrase repression.
    Int J Antimicrob Agents. 2019;53:491-499.
    PubMed     Abstract available


  105. ZHANG X, Li Y, Wang W, Zhang J, et al
    Identification of an anti-Gram-negative bacteria agent disrupting the interaction between lipopolysaccharide transporters LptA and LptC.
    Int J Antimicrob Agents. 2019;53:442-448.
    PubMed     Abstract available


  106. SAIDANI N, Lagier JC, Cassir N, Million M, et al
    Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.
    Int J Antimicrob Agents. 2019;53:355-361.
    PubMed     Abstract available


  107. VISCA P, Pisa F, Imperi F
    The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.
    Int J Antimicrob Agents. 2019;53:449-455.
    PubMed     Abstract available


  108. DURAND GA, Raoult D, Dubourg G
    Antibiotic discovery: history, methods and perspectives.
    Int J Antimicrob Agents. 2019;53:371-382.
    PubMed     Abstract available


  109. DE LA CALLE C, Rodriguez O, Morata L, Marco F, et al
    Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    Int J Antimicrob Agents. 2019;53:520-524.
    PubMed     Abstract available


  110. KARLOWSKY JA, Hackel MA, Tsuji M, Yamano Y, et al
    In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
    Int J Antimicrob Agents. 2019;53:456-466.
    PubMed     Abstract available


  111. BASSETTI M, Castaldo N, Cattelan A, Mussini C, et al
    Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
    Int J Antimicrob Agents. 2019;53:408-415.
    PubMed     Abstract available


    March 2019
  112. RAMSEY EG, Royer J, Bookstaver PB, Justo JA, et al
    Seasonal Variation in Antimicrobial Resistance Rates of Community-Acquired Escherichia coli Bloodstream Isolates.
    Int J Antimicrob Agents. 2019 Mar 15. pii: S0924-8579(19)30063.
    PubMed     Abstract available


  113. TEO JQ, Chang CW, Leck H, Tang CY, et al
    Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Int J Antimicrob Agents. 2019 Mar 14. pii: S0924-8579(19)30064.
    PubMed     Abstract available


  114. DAVIDO B, Batista R, Dinh A, de Truchis P, et al
    Fifty shades of graft: how to improve efficacy of Fecal Microbiota Transplantation (FMT) for decolonization of Antibiotic-Resistant Bacteria (ARB)?
    Int J Antimicrob Agents. 2019 Mar 14. pii: S0924-8579(19)30061.
    PubMed     Abstract available


  115. LEE T, Pang S, Abraham S, Coombs GW, et al
    Molecular characterization and evolution of the first outbreak of vancomycin resistant Enterococcus faecium in Western Australia.
    Int J Antimicrob Agents. 2019 Mar 6. pii: S0924-8579(19)30039.
    PubMed     Abstract available


  116. GOLDSTEIN E, MacFadden DR, Karaca Z, Steiner CA, et al
    Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
    Int J Antimicrob Agents. 2019 Mar 6. pii: S0924-8579(19)30056.
    PubMed     Abstract available


  117. GAO Q, Wu S, Xu T, Zhao X, et al
    Emergence of Carbapenem Resistance in Bacteroides fragilis in China.
    Int J Antimicrob Agents. 2019 Mar 1. pii: S0924-8579(19)30047.
    PubMed     Abstract available


  118. VATS S, Shanker A
    Groups of coevolving positions provide drug resistance to Mycobacterium tuberculosis: A study using targets of first-line antituberculosis drugs.
    Int J Antimicrob Agents. 2019;53:197-202.
    PubMed     Abstract available


  119. NAGANO N, Koide S, Hayashi W, Taniguchi Y, et al
    Population-level transition of capsular polysaccharide types among sequence type 1 group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic.
    Int J Antimicrob Agents. 2019;53:203-210.
    PubMed     Abstract available


  120. KLEIN S, Menz MD, Zanger P, Heeg K, et al
    Increase in the prevalence of Panton-Valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region, Germany, 2012-2016.
    Int J Antimicrob Agents. 2019;53:261-267.
    PubMed     Abstract available


  121. VAN DE PEPPEL RJ, van der Beek MT, Visser LG, de Boer MGJ, et al
    Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
    Int J Antimicrob Agents. 2019;53:284-293.
    PubMed     Abstract available


  122. PAPADOPOULOS A, Ribera A, Mavrogenis AF, Rodriguez-Pardo D, et al
    Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
    Int J Antimicrob Agents. 2019;53:294-301.
    PubMed     Abstract available


  123. JOUSSET AB, Bernabeu S, Bonnin RA, Creton E, et al
    Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance.
    Int J Antimicrob Agents. 2019;53:302-309.
    PubMed     Abstract available


  124. KOULENTI D, Song A, Ellingboe A, Abdul-Aziz MH, et al
    Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Int J Antimicrob Agents. 2019;53:211-224.
    PubMed     Abstract available


  125. HEINRICHS MT, Drusano GL, Brown DL, Maynard MS, et al
    Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation.
    Int J Antimicrob Agents. 2019;53:275-283.
    PubMed     Abstract available


  126. MENDONCA AA, de Morais MA Jr, Cabrera MZ
    Cysteine induces resistance of lactobacilli to erythromycin and azithromycin.
    Int J Antimicrob Agents. 2019;53:352-353.
    PubMed    


    February 2019
  127. LIU WL, Huang YT, Hsieh MH, Hii IM, et al
    Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
    Int J Antimicrob Agents. 2019;53:185-189.
    PubMed     Abstract available


  128. KAZMIERCZAK KM, Tsuji M, Wise MG, Hackel M, et al
    In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-beta-lactamase-producing isolates (SIDERO-W
    Int J Antimicrob Agents. 2019;53:177-184.
    PubMed     Abstract available


  129. POULAKOU G, Renieris G, Sabrakos L, Zarkotou O, et al
    Daptomycin as adjunctive treatment for experimental infection by Acinetobacter baumannii with resistance to colistin.
    Int J Antimicrob Agents. 2019;53:190-194.
    PubMed     Abstract available


  130. CHEN S, Liu H, Liang W, Hong L, et al
    Insertion sequences in the CRISPR-Cas system regulate horizontal antimicrobial resistance gene transfer in Shigella strains.
    Int J Antimicrob Agents. 2019;53:109-115.
    PubMed     Abstract available


  131. QUEK WM, Teng CB, Tan YZ, Chong K, et al
    Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly.
    Int J Antimicrob Agents. 2019;53:195-196.
    PubMed    


    January 2019
  132. CHIRAKUL S, Somprasong N, Norris MH, Wuthiekanun V, et al
    Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
    Int J Antimicrob Agents. 2019 Jan 9. pii: S0924-8579(19)30003.
    PubMed     Abstract available


  133. FALAGAS ME, Athanasaki F, Voulgaris GL, Triarides NA, et al
    Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.
    Int J Antimicrob Agents. 2019;53:22-28.
    PubMed     Abstract available


  134. DONG H, Xiang H, Mu D, Wang D, et al
    Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli.
    Int J Antimicrob Agents. 2019;53:1-8.
    PubMed     Abstract available


  135. OTTO RG, van Gorp E, Kloezen W, Meletiadis J, et al
    An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.
    Int J Antimicrob Agents. 2019;53:34-39.
    PubMed     Abstract available


  136. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Merino I, et al
    Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.
    Int J Antimicrob Agents. 2019;53:84-88.
    PubMed     Abstract available


  137. BERNARDINI A, Cuesta T, Tomas A, Bengoechea JA, et al
    The intrinsic resistome of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2019;53:29-33.
    PubMed     Abstract available


  138. NGUYEN T, Akhavan S, Caby F, Bonyhay L, et al
    Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
    Int J Antimicrob Agents. 2019;53:80-83.
    PubMed     Abstract available


    December 2018
  139. OSTRER L, Khodursky RF, Johnson JR, Hiasa H, et al
    Analysis of Mutational Patterns in Quinolone Resistance-Determining Regions of GyrA and ParC of Clinical Isolates.
    Int J Antimicrob Agents. 2018 Dec 21. pii: S0924-8579(18)30366.
    PubMed     Abstract available


  140. AHMAD N, Ali SM, Khan AU
    Molecular characterization of novel sequence type of carbapenem-resistant NDM-1 producing Klebsiella pneumoniae in NICU of Indian Hospital.
    Int J Antimicrob Agents. 2018 Dec 19. pii: S0924-8579(18)30367.
    PubMed     Abstract available


  141. KHAWCHAROENPORN T, Chuncharunee A, Maluangnon C, Taweesakulvashra T, et al
    Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia.
    Int J Antimicrob Agents. 2018;52:828-834.
    PubMed     Abstract available


  142. ZINNER SH, Golikova MV, Strukova EN, Portnoy YA, et al
    Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
    Int J Antimicrob Agents. 2018;52:854-860.
    PubMed     Abstract available


  143. BENDER JK, Fleige C, Lange D, Klare I, et al
    Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates.
    Int J Antimicrob Agents. 2018;52:819-827.
    PubMed     Abstract available


  144. ZHANG JM, Wang Q, Han TY, Liu JH, et al
    Structure analysis of transposons carrying the aac(6')-aph(2'') gene in Enterococcus faecalis isolated in Beijing, China, and comparison of their transfer efficiency.
    Int J Antimicrob Agents. 2018;52:799-804.
    PubMed     Abstract available


  145. TANFOUS FB, Raddaoui A, Chebbi Y, Achour W, et al
    Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Int J Antimicrob Agents. 2018;52:861-865.
    PubMed     Abstract available


  146. LOOSE M, Naber KG, Hu Y, Coates A, et al
    Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
    Int J Antimicrob Agents. 2018;52:783-789.
    PubMed     Abstract available


  147. KANZARI L, Ferjani S, Saidani M, Hamzaoui Z, et al
    First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated blaNDM-1 in a Tunisian intensive care unit.
    Int J Antimicrob Agents. 2018;52:906-909.
    PubMed     Abstract available


  148. CHOUCHANI C, Rolain JM, Ghrairi T
    Recent advances in antimicrobial and bacterial resistance.
    Int J Antimicrob Agents. 2018;52:869-870.
    PubMed    


    November 2018
  149. LAZARO-PERONA F, Sotillo A, Troyano-Hernaez P, Gomez-Gil R, et al
    Genomic path to pandrug resistance in a clinical isolate of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018;52:713-718.
    PubMed     Abstract available


  150. MCKAMEY L, Venugopalan V, Cherabuddi K, Borgert S, et al
    Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
    Int J Antimicrob Agents. 2018;52:719-723.
    PubMed     Abstract available


  151. ABDOLRASOULI A, Scourfield A, Rhodes J, Shah A, et al
    High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Int J Antimicrob Agents. 2018;52:637-642.
    PubMed     Abstract available


  152. RUI Y, Lu W, Li S, Cheng C, et al
    Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China.
    Int J Antimicrob Agents. 2018;52:571-576.
    PubMed     Abstract available


    October 2018
  153. KOSTYANEV T, Vilken T, Lammens C, Timbermont L, et al
    Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories part of the COMBACTE network: a COMBACTE LAB-Net survey.
    Int J Antimicrob Agents. 2018 Oct 31. pii: S0924-8579(18)30305.
    PubMed     Abstract available


  154. ZHONG H, Zhao XY, Zhang ZL, Gu ZC, et al
    Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;52:443-450.
    PubMed     Abstract available


  155. O'DONNELL JN, Rhodes NJ, Lopez J, Jett R, et al
    Carbapenems vs. alternative beta-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;52:451-458.
    PubMed     Abstract available


    September 2018
  156. OLIVEIRA FA, Zaccariotto TR, Piveta C, Hofling CC, et al
    MCR-1-positive colistin-resistant Escherichia coli in immunocompromised hospitalised patients.
    Int J Antimicrob Agents. 2018;52:438-440.
    PubMed    


  157. MCKINNON J, Roy Chowdhury P, Djordjevic SP
    Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis.
    Int J Antimicrob Agents. 2018;52:430-435.
    PubMed     Abstract available


  158. TANSARLI GS, Papaparaskevas J, Balaska M, Samarkos M, et al
    Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Int J Antimicrob Agents. 2018;52:397-403.
    PubMed     Abstract available


  159. CHEN CM, Huang M, Wu HJ, Guo MK, et al
    Identification of CFE-2, a new plasmid-encoded AmpC beta-lactamase from a clinical isolate of Citrobacter freundii.
    Int J Antimicrob Agents. 2018;52:421-424.
    PubMed     Abstract available


  160. KIM SJ, Ko KS
    Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018;52:425-429.
    PubMed     Abstract available


  161. MACAUX L, Ndoye O, Cordel H, Pomares TB, et al
    Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
    Int J Antimicrob Agents. 2018;52:385-389.
    PubMed     Abstract available


  162. DIEP JK, Covelli J, Sharma R, Ruszaj DM, et al
    Comparison of the composition and in vitro activity of polymyxin B products.
    Int J Antimicrob Agents. 2018;52:365-371.
    PubMed     Abstract available


  163. LIM SC, Androga GO, Knight DR, Moono P, et al
    Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Int J Antimicrob Agents. 2018;52:411-415.
    PubMed     Abstract available


  164. COURTOIS N, Caspar Y, Maurin M
    Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Int J Antimicrob Agents. 2018;52:358-364.
    PubMed     Abstract available


  165. CROUGHS PD, Klaassen CHW, van Rosmalen J, Maghdid DM, et al
    Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Int J Antimicrob Agents. 2018;52:407-410.
    PubMed     Abstract available


  166. KHOO AL, Zhao YJ, Teng M, Ying D, et al
    Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Int J Antimicrob Agents. 2018;52:350-357.
    PubMed     Abstract available


  167. LOMOVSKAYA O, Sun D, Rubio-Aparicio D, Nelson KJ, et al
    Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:404-406.
    PubMed     Abstract available


  168. SCOTT AM, Beller E, Glasziou P, Clark J, et al
    Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review.
    Int J Antimicrob Agents. 2018;52:316-323.
    PubMed     Abstract available


  169. PROTONOTARIOU E, Poulou A, Politi L, Sgouropoulos I, et al
    Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Int J Antimicrob Agents. 2018;52:331-337.
    PubMed     Abstract available


    August 2018
  170. MOGLE BT, Steele JM, Seabury RW, Dang UJ, et al
    Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Int J Antimicrob Agents. 2018 Aug 31. pii: S0924-8579(18)30250.
    PubMed     Abstract available


  171. HE JM, Sun SC, Sun ZL, Chen JT, et al
    Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antibiotic resistance of drug-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2018 Aug 31. pii: S0924-8579(18)30247.
    PubMed     Abstract available


  172. RAOULT D
    The theory of "Eat me cake", or the genetic cannibalism of the enemy: a cause of vanishing antibiotic resistance.
    Int J Antimicrob Agents. 2018 Aug 24. pii: S0924-8579(18)30244.
    PubMed    


  173. LISHMAN H, Costelloe C, Hopkins S, Johnson AP, et al
    Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antibiotic resistance: an ecological study.
    Int J Antimicrob Agents. 2018 Aug 23. pii: S0924-8579(18)30239.
    PubMed     Abstract available


  174. SHIMA K, Ledig S, Loeper N, Schiefer A, et al
    Effective inhibition of rifampin-resistant Chlamydia trachomatis by the novel DNA-dependent RNA-polymerase inhibitor Corallopyronin A.
    Int J Antimicrob Agents. 2018 Aug 6. pii: S0924-8579(18)30224.
    PubMed    


  175. CARMEN L, Andrea DC, Eleonora M, Ilaria P, et al
    Assessing antibiotic resistance gene load in vegan, vegetarian and omnivore human gut microbiota.
    Int J Antimicrob Agents. 2018 Aug 3. pii: S0924-8579(18)30222.
    PubMed     Abstract available


  176. CHUANG L, Ratnayake L
    Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection.
    Int J Antimicrob Agents. 2018 Aug 3. pii: S0924-8579(18)30207.
    PubMed    


  177. KLIBI A, Maaroufi A, Torres C, Jouini A, et al
    Detection and characterization of methicillin resistant and susceptible coagulase-negative Staphylococci in milk from cows with clinical mastitis in Tunisia.
    Int J Antimicrob Agents. 2018 Aug 2. pii: S0924-8579(18)30225.
    PubMed     Abstract available


  178. ZHANG X, Zhang Y, Wang F, Wang C, et al
    Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
    Int J Antimicrob Agents. 2018;52:226-232.
    PubMed     Abstract available


  179. FANG H, Feng J, Xu Y, Zhang Y, et al
    Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
    Int J Antimicrob Agents. 2018;52:210-217.
    PubMed     Abstract available


  180. GUO X, Wu J, Wei F, Ouyang Y, et al
    Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    Int J Antimicrob Agents. 2018;52:201-209.
    PubMed     Abstract available


  181. RECIO R, Villa J, Viedma E, Orellana MA, et al
    Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Int J Antimicrob Agents. 2018;52:172-179.
    PubMed     Abstract available


  182. TAYLOR E, Sriskandan S, Woodford N, Hopkins KL, et al
    High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK and Ireland.
    Int J Antimicrob Agents. 2018;52:278-282.
    PubMed     Abstract available


  183. GU D, Lv H, Sun Q, Shu L, et al
    Emergence of tet(A) and blaKPC-2 co-carrying plasmid from a ST11 hypervirulent Klebsiella pneumoniae isolate in patient's gut.
    Int J Antimicrob Agents. 2018;52:307-308.
    PubMed    


  184. NGUYEN LTT, Roman F, Morikawa K, Trincado P, et al
    Prevalence of pSCFS7-like vectors among cfr-positive staphylococcal population in Spain.
    Int J Antimicrob Agents. 2018;52:305-306.
    PubMed    


  185. LI R, Xie M, Chan EWC, Chen S, et al
    Rapid resolution of multi-drug resistance bacterial genome harbouring mcr-1 and blaCMY-2 using MinION sequencing platform.
    Int J Antimicrob Agents. 2018;52:303-304.
    PubMed    


  186. GREENWOOD B, Meunier D, Hopkins KL, Pike R, et al
    Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum beta-lactamases in the UK: relatedness and resistance.
    Int J Antimicrob Agents. 2018;52:301-302.
    PubMed    


    July 2018
  187. YAN Q, Karau MJ, Raval YS, Patel R, et al
    in vitro Activity of Oritavancin in Combination with Rifampin or Gentamicin Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus epidermidis Biofilms.
    Int J Antimicrob Agents. 2018 Jul 23. pii: S0924-8579(18)30203.
    PubMed     Abstract available


  188. SANTONA A, Taviani E, Hoang HM, Fiamma M, et al
    Emergence of unusual vanA/vanB2 genotype in a highly mutated vanB2-Vancomycin Resistant Hospital Associated E. faecium background, in Vietnam.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30197.
    PubMed     Abstract available


  189. SEIFERT H, Blondeau J, Dowzicky MJ
    In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance - a report from the T.E.S.T. study.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30194.
    PubMed     Abstract available


  190. BARRADO L, Perez-Vazquez M, Del Pozo JL, Martin-Salas C, et al
    Clonal transmission of NDM-5-producing Escherichia coli belonging to high-risk sequence type ST405.
    Int J Antimicrob Agents. 2018;52:123-124.
    PubMed    


  191. MONACO F, Mento GD, Cuscino N, Conaldi PG, et al
    Infant colonisation with Escherichia coli and Klebsiella pneumoniae strains co-harbouring blaOXA-48 and blaNDM-1 carbapenemases genes: a case report.
    Int J Antimicrob Agents. 2018;52:121-122.
    PubMed    


  192. PEYCLIT L, Baron SA, Yousfi H, Rolain JM, et al
    Zidovudine: A salvage therapy for mcr-1 plasmid-mediated colistin-resistant bacterial infections?
    Int J Antimicrob Agents. 2018;52:11-13.
    PubMed    


  193. WANG J, Cao L, Yang X, Wu Q, et al
    Transcriptional analysis reveals the critical role of RNA polymerase-binding transcription factor, DksA, in regulating multi-drug resistance of Escherichia coli.
    Int J Antimicrob Agents. 2018;52:63-69.
    PubMed     Abstract available


  194. DOMHAN C, Uhl P, Meinhardt A, Zimmermann S, et al
    A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Int J Antimicrob Agents. 2018;52:52-62.
    PubMed     Abstract available


  195. GARCIA V, Garcia-Menino I, Mora A, Flament-Simon SC, et al
    Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006-2017).
    Int J Antimicrob Agents. 2018;52:104-108.
    PubMed     Abstract available


  196. MOUBARECK CA, Mouftah SF, Pal T, Ghazawi A, et al
    Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
    Int J Antimicrob Agents. 2018;52:90-95.
    PubMed     Abstract available


  197. MA Q, Huang Y, Wang J, Xu X, et al
    Multidrug-resistant Shigella sonnei carrying the plasmid-mediated mcr-1 gene in China.
    Int J Antimicrob Agents. 2018;52:14-21.
    PubMed     Abstract available


  198. SHUKLA M, Soni I, Matsuyama K, Tran T, et al
    Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:22-27.
    PubMed     Abstract available


  199. GIUFRE M, Errico G, Accogli M, Monaco M, et al
    Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy.
    Int J Antimicrob Agents. 2018;52:76-81.
    PubMed     Abstract available


  200. BULMAN ZP, Zhao M, Satlin MJ, Chen L, et al
    Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
    Int J Antimicrob Agents. 2018;52:114-118.
    PubMed     Abstract available


    June 2018
  201. LIN YT, Cheng YH, Juan CH, Wu PF, et al
    High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.
    Int J Antimicrob Agents. 2018 Jun 12. pii: S0924-8579(18)30165.
    PubMed     Abstract available


  202. MITGANG EA, Hartley DM, Malchione MD, Koch M, et al
    Review and Mapping of Carbapenem-resistant Enterobacteriaceae in Africa: Using Diverse Data to Inform Surveillance Gaps.
    Int J Antimicrob Agents. 2018 Jun 1. pii: S0924-8579(18)30157.
    PubMed     Abstract available


  203. YOKOTA SI, Hakamada H, Yamamoto S, Sato T, et al
    Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Int J Antimicrob Agents. 2018;51:888-896.
    PubMed     Abstract available


  204. ALONSO CA, Cortes-Cortes G, Maamar E, Masso M, et al
    Molecular diversity and conjugal transferability of class 2 integrons among Escherichia coli isolates from food, animal and human sources.
    Int J Antimicrob Agents. 2018;51:905-911.
    PubMed     Abstract available


  205. PETER S, Bezdan D, Oberhettinger P, Vogel W, et al
    Whole-genome sequencing enabling the detection of a colistin-resistant hypermutating Citrobacter werkmanii strain harbouring a novel metallo-beta-lactamase VIM-48.
    Int J Antimicrob Agents. 2018;51:867-874.
    PubMed     Abstract available


  206. PFALLER MA, Huband MD, Streit JM, Flamm RK, et al
    Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Int J Antimicrob Agents. 2018;51:848-853.
    PubMed     Abstract available


  207. SUN J, Li XP, Fang LX, Sun RY, et al
    Co-occurrence of mcr-1 in the chromosome and on an IncHI2 plasmid: persistence of colistin resistance in Escherichia coli.
    Int J Antimicrob Agents. 2018;51:842-847.
    PubMed     Abstract available


  208. PEROZZIELLO A, Routelous C, Charani E, Truel A, et al
    Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study.
    Int J Antimicrob Agents. 2018;51:829-835.
    PubMed     Abstract available


  209. ZHOU K, Luo Q, Wang Q, Huang C, et al
    Silent transmission of an IS1294b-deactivated mcr-1 gene with inducible colistin resistance.
    Int J Antimicrob Agents. 2018;51:822-828.
    PubMed     Abstract available


  210. LIU J, Yang Y, Li Y, Liu D, et al
    Isolation of an IncP-1 plasmid harbouring mcr-1 from a chicken isolate of Citrobacter braakii in China.
    Int J Antimicrob Agents. 2018;51:936-940.
    PubMed     Abstract available


    May 2018
  211. MAFIZ A, Perera LN, He Y, Zhang W, et al
    A Case Study on Soil Antibiotic Resistome in an Urban Community Garden.
    Int J Antimicrob Agents. 2018 May 29. pii: S0924-8579(18)30147.
    PubMed     Abstract available


  212. MENICHETTI F, Falcone M, Lopalco P, Tascini C, et al
    The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy.
    Int J Antimicrob Agents. 2018 May 23. pii: S0924-8579(18)30141.
    PubMed     Abstract available


  213. YAHIA HB, Chairat S, Hamdi N, Gharsa H, et al
    Antimicrobial resistance and genetic lineages of faecal enterococci of wild birds: Emergence of vanA and vanB2 harboring Enterococcus faecalis.
    Int J Antimicrob Agents. 2018 May 14. pii: S0924-8579(18)30136.
    PubMed     Abstract available


  214. LIU YH, Huang YT, Liao CH, Hsueh PR, et al
    Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
    Int J Antimicrob Agents. 2018;51:768-774.
    PubMed     Abstract available


  215. OKDAH L, Le Page S, Olaitan AO, Dubourg G, et al
    New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Int J Antimicrob Agents. 2018;51:775-783.
    PubMed     Abstract available


  216. WANG R, Liu Y, Zhang Q, Jin L, et al
    The prevalence of colistin resistance in Escherichia coli and Klebsiella pneumoniae isolated from food animals in China: coexistence of mcr-1 and blaNDM with low fitness cost.
    Int J Antimicrob Agents. 2018;51:739-744.
    PubMed     Abstract available


  217. SORSTEDT E, Carlander C, Flamholc L, Hejdeman B, et al
    Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations.
    Int J Antimicrob Agents. 2018;51:733-738.
    PubMed     Abstract available


  218. THABIT AK, Monogue ML, Newman JV, Nicolau DP, et al
    Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis.
    Int J Antimicrob Agents. 2018;51:727-732.
    PubMed     Abstract available


  219. RADDAOUI A, Ben Tanfous F, Achour W, Baaboura R, et al
    Description of a novel mutation in the atpC gene in optochin-resistant Streptococcus pneumoniae strains isolates from Tunisia.
    Int J Antimicrob Agents. 2018;51:803-805.
    PubMed     Abstract available


  220. MERCURO NJ, Stogsdill P, Wungwattana M
    Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus beta-lactams.
    Int J Antimicrob Agents. 2018;51:687-692.
    PubMed     Abstract available


  221. FERREIRA ML, Goncalves IR, Araujo BF, Royer S, et al
    Detection of ISEcp1-associated blaCTX-M-15-mediated resistance to colistin in KPC-producing Klebsiella pneumoniae isolates.
    Int J Antimicrob Agents. 2018;51:810-811.
    PubMed    


    April 2018
  222. RADDAOUI A, Tanfous FB, Chebbi Y, Achour W, et al
    High prevalence of multidrug resistant international clones among macrolide resistant Streptococcus pneumoniae strains in immunocompromised Patients in Tunisia.
    Int J Antimicrob Agents. 2018 Apr 23. pii: S0924-8579(18)30117.
    PubMed     Abstract available


  223. LEINWEBER H, Alotaibi SMI, Overballe-Petersen S, Hansen F, et al
    Vancomycin resistance in Enterococcus faecium isolated from Danish chicken meat is located on a pVEF4-like plasmid persisting in poultry for 18 years.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30097.
    PubMed     Abstract available


  224. HAMZAOUI Z, Ocampo-Sosa A, Martinez MF, Landolsi S, et al
    Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC in conferring carbapenem resistance among non-producing carbapenemase-Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30098.
    PubMed     Abstract available


  225. ADHIKARI S, Piza M, Taylor P, Deshpande K, et al
    Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis.
    Int J Antimicrob Agents. 2018;51:620-628.
    PubMed     Abstract available


  226. OHNUMA T, Hayashi Y, Yamashita K, Marquess J, et al
    A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.
    Int J Antimicrob Agents. 2018;51:636-641.
    PubMed     Abstract available


  227. VARDAKAS KZ, Mavroudis AD, Georgiou M, Falagas ME, et al
    Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:535-547.
    PubMed     Abstract available


  228. HUANG J, Zhu Y, Han ML, Li M, et al
    Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
    Int J Antimicrob Agents. 2018;51:586-593.
    PubMed     Abstract available


  229. CARRARA E, Pfeffer I, Zusman O, Leibovici L, et al
    Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:548-553.
    PubMed     Abstract available


  230. PFALLER MA, Flamm RK, Castanheira M, Sader HS, et al
    Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Int J Antimicrob Agents. 2018;51:608-611.
    PubMed     Abstract available


  231. NGUYEN PC, Madani A, Santucci P, Martin BP, et al
    Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
    Int J Antimicrob Agents. 2018;51:651-654.
    PubMed     Abstract available


  232. LI R, Yu H, Xie M, Chen K, et al
    Genetic basis of chromosomally-encoded mcr-1 gene.
    Int J Antimicrob Agents. 2018;51:578-585.
    PubMed     Abstract available


  233. TIETGEN M, Semmler T, Riedel-Christ S, Kempf VAJ, et al
    Impact of the colistin resistance gene mcr-1 on bacterial fitness.
    Int J Antimicrob Agents. 2018;51:554-561.
    PubMed     Abstract available


  234. LINDGREN AK, Nilsson AC, Akesson P, Gustafsson E, et al
    Eradication of methicillin-resistant Staphylococcus aureus (MRSA) throat carriage: a randomised trial comparing topical treatment with rifampicin-based systemic therapy.
    Int J Antimicrob Agents. 2018;51:642-645.
    PubMed     Abstract available


    March 2018
  235. OH E, Bae J, Kumar A, Choi HJ, et al
    Antioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with bacitracin.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30077.
    PubMed     Abstract available


  236. SANTOS L, Ramos F
    Antimicrobial resistance in aquaculture: current knowledge and alternatives to tackle the problem.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30081.
    PubMed     Abstract available


  237. FALAGAS ME, Skalidis T, Vardakas KZ, Voulgaris GL, et al
    Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Int J Antimicrob Agents. 2018 Mar 17. pii: S0924-8579(18)30080.
    PubMed     Abstract available


  238. PFALLER MA, Huband MD, Mendes RE, Flamm RK, et al
    In vitro activity of meropenem-vaborbactam and characterization of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem-vaborbactam surveillance program.
    Int J Antimicrob Agents. 2018 Mar 3. pii: S0924-8579(18)30064.
    PubMed     Abstract available


  239. HUANG YT, Liao CH, Chen SY, Hsu HS, et al
    Emergence of multidrug-resistant sequence type 45 strains among borderline oxacillin-resistant mecA-positive Staphylococcus aureus causing bacteraemia in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018 Mar 2. pii: S0924-8579(18)30052.
    PubMed     Abstract available


  240. VINUE L, Hooper DC, Jacoby GA
    Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Int J Antimicrob Agents. 2018;51:479-483.
    PubMed     Abstract available


  241. JONES BM, Hersey RM, Trestman IJ, Bland CM, et al
    Successful treatment of a penicillin-intermediate and ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve endocarditis with vancomycin.
    Int J Antimicrob Agents. 2018;51:508-510.
    PubMed     Abstract available


  242. DIETL B, Sanchez I, Arcenillas P, Cuchi E, et al
    Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
    Int J Antimicrob Agents. 2018;51:498-502.
    PubMed     Abstract available


  243. BOUSQUET A, Bugier S, Larreche S, Bigaillon C, et al
    Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
    Int J Antimicrob Agents. 2018;51:493-497.
    PubMed     Abstract available


  244. KHAN DD, Lagerback P, Malmberg C, Kristoffersson AN, et al
    Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
    Int J Antimicrob Agents. 2018;51:399-406.
    PubMed     Abstract available


  245. HE J, Jia X, Yang S, Xu X, et al
    Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections.
    Int J Antimicrob Agents. 2018;51:413-421.
    PubMed     Abstract available


  246. BRAUN G, Cayo R, Matos AP, de Mello Fonseca J, et al
    Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period.
    Int J Antimicrob Agents. 2018;51:522-527.
    PubMed     Abstract available


  247. CHIEN YC, Liao CH, Sheng WH, Chien JY, et al
    Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018;51:357-364.
    PubMed     Abstract available


  248. TACAO M, Araujo S, Vendas M, Alves A, et al
    Shewanella species as the origin of blaOXA-48 genes: insights into gene diversity, associated phenotypes and possible transfer mechanisms.
    Int J Antimicrob Agents. 2018;51:340-348.
    PubMed     Abstract available


  249. HERNANDEZ M, Quijada NM, Lorente LL, de Frutos M, et al
    Infrequent isolation of extensively drug-resistant (XDR) Klebsiella pneumoniae resistant to colistin in Spain.
    Int J Antimicrob Agents. 2018;51:531-533.
    PubMed    


  250. BERNASCONI OJ, Dona V, Pires J, Kuenzli E, et al
    Deciphering the complete deletion of the mgrB locus in an unusual colistin-resistant Klebsiella pneumoniae isolate colonising the gut of a traveller returning from India.
    Int J Antimicrob Agents. 2018;51:529-531.
    PubMed    


  251. SCHIRMEIER E, Zimmermann P, Hofmann V, Biebl M, et al
    Inhibitory and bactericidal effect of Artilysin((R)) Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates.
    Int J Antimicrob Agents. 2018;51:528-529.
    PubMed    


    February 2018
  252. STEWART A, Roberts JA, Wallis SC, Allworth AM, et al
    Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat A carbapenem-resistant Pseudomonas aeruginosa lung abscess on an outpatient antimicrobial program.
    Int J Antimicrob Agents. 2018 Feb 19. pii: S0924-8579(18)30046.
    PubMed    


  253. VUBIL D, Balleste-Delpierre C, Mabunda R, Acacio S, et al
    Antibiotic resistance and molecular characterization of Shigella isolates recovered from children less than 5 years in Manhica, Southern Mozambique.
    Int J Antimicrob Agents. 2018 Feb 12. pii: S0924-8579(18)30043.
    PubMed     Abstract available


  254. MOHAMMAD H, AbdelKhalek A, Abutaleb NS, Seleem MN, et al
    Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
    Int J Antimicrob Agents. 2018 Feb 9. pii: S0924-8579(18)30041.
    PubMed     Abstract available


  255. SANTEVECCHI BA, Smith TT, MacVane SH
    Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30019.
    PubMed     Abstract available


  256. SEO MR, Kim J, Lee Y, Lim DG, et al
    Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30036.
    PubMed     Abstract available


  257. BARTOLETTI M, Tedeschi S, Pascale R, Raumer L, et al
    Differences in the rate of carbapenem-resistant enterobacteriaceae colonization or clostridium difficile infection following frontline treatment with tigecycline versus meropenem for intra-abdominal infections.
    Int J Antimicrob Agents. 2018 Feb 1. pii: S0924-8579(18)30013.
    PubMed     Abstract available


  258. JAIDANE N, Naas T, Mansour W, Radhia BB, et al
    Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;51:266-269.
    PubMed     Abstract available


  259. GHAZI IM, Monogue ML, Tsuji M, Nicolau DP, et al
    Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.
    Int J Antimicrob Agents. 2018;51:206-212.
    PubMed     Abstract available


  260. AGNOLETTI F, Brunetta R, Bano L, Drigo I, et al
    Longitudinal study on antimicrobial consumption and resistance in rabbit farming.
    Int J Antimicrob Agents. 2018;51:197-205.
    PubMed     Abstract available


  261. GIORDANO C, Barnini S, Tsioutis C, Chlebowicz MA, et al
    Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Int J Antimicrob Agents. 2018;51:260-265.
    PubMed     Abstract available


  262. KAUSHIK M, Kumar S, Kapoor RK, Virdi JS, et al
    Integrons in Enterobacteriaceae: diversity, distribution and epidemiology.
    Int J Antimicrob Agents. 2018;51:167-176.
    PubMed     Abstract available


  263. CABANEL N, Bouchier C, Rajerison M, Carniel E, et al
    Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Int J Antimicrob Agents. 2018;51:249-254.
    PubMed     Abstract available


  264. PFALLER MA, Shortridge D, Sader HS, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillanc
    Int J Antimicrob Agents. 2018;51:181-189.
    PubMed     Abstract available


  265. HILLE K, Roschanski N, Ruddat I, Woydt J, et al
    Investigation of potential risk factors for the occurrence of Escherichia coli isolates from German fattening pig farms harbouring the mcr-1 colistin-resistance gene.
    Int J Antimicrob Agents. 2018;51:177-180.
    PubMed     Abstract available


  266. SEIFERT H, Korber-Irrgang B, Kresken M
    In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
    Int J Antimicrob Agents. 2018;51:227-234.
    PubMed     Abstract available


  267. LARSSON DGJ
    Risks of using the natural defence of commensal bacteria as antibiotics call for research and regulation.
    Int J Antimicrob Agents. 2018;51:277-278.
    PubMed    


  268. ZHENG B, Lv T, Xu H, Yu X, et al
    Discovery and characterisation of an escherichia coli ST206 strain producing NDM-5 and MCR-1 from a patient with acute diarrhoea in China.
    Int J Antimicrob Agents. 2018;51:273-275.
    PubMed    


  269. CHIEM K, Hue F, Magallon J, Tolmasky ME, et al
    Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
    Int J Antimicrob Agents. 2018;51:271-273.
    PubMed    


  270. HO PL, Yau CY, Wang Y, Chow KH, et al
    Determination of the mutant-prevention concentration of imipenem for the two imipenem-susceptible Bacteroides fragilis strains, Q1F2 (cfiA-positive) and ATCC 25282 (cfiA-negative).
    Int J Antimicrob Agents. 2018;51:270-271.
    PubMed    


    January 2018
  271. LIN YT, Hung WC, Tsai JC, Leong KH, et al
    Wide dissemination of SCCfusC in fusidic acid resistant coagulase-negative staphylococci and implication for its spreading to methicillin-resistant S. aureus in Taiwan.
    Int J Antimicrob Agents. 2018 Jan 30. pii: S0924-8579(18)30031.
    PubMed     Abstract available


  272. GARCIA-CASTILLO M, Garcia-Fernandez S, Gomez-Gil R, Pitart C, et al
    Activity of ceftazidime-avibactam against carbapenemase-producing enterobacteriaceae from urine samples obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    Int J Antimicrob Agents. 2018 Jan 22. pii: S0924-8579(18)30014.
    PubMed     Abstract available


  273. ZHANG G, Lin X, Cai J, Zhang R, et al
    Characteristics of clinical and environmental vanM-carrying vancomycin-resistant enterococci isolates from an infected patient.
    Int J Antimicrob Agents. 2018 Jan 12. pii: S0924-8579(18)30006.
    PubMed     Abstract available


  274. LIEGEON G, Delory T, Picardeau M
    Antibiotic susceptibilities of livestock isolates of leptospira.
    Int J Antimicrob Agents. 2018 Jan 3. pii: S0924-8579(17)30467.
    PubMed     Abstract available


  275. LU M, Yu C, Cui X, Shi J, et al
    Gentamicin synergises with azoles against drug-resistant Candida albicans.
    Int J Antimicrob Agents. 2018;51:107-114.
    PubMed     Abstract available


  276. LIU J, Yang L, Chen D, Peters BM, et al
    Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2018;51:145-150.
    PubMed     Abstract available


  277. WANG R, Liu H, Zhao X, Li J, et al
    IncA/C plasmids conferring high azithromycin resistance in vibrio cholerae.
    Int J Antimicrob Agents. 2018;51:140-144.
    PubMed     Abstract available


  278. PARVEZ S, Khan AU
    Hospital sewage water: a reservoir for variants of New Delhi metallo-beta-lactamase (NDM)- and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
    Int J Antimicrob Agents. 2018;51:82-88.
    PubMed     Abstract available


  279. VESTERGAARD M, Nohr-Meldgaard K, Ingmer H
    Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus.
    Int J Antimicrob Agents. 2018;51:132-135.
    PubMed     Abstract available


  280. LUO HY, Liu MF, Wang MS, Zhao XX, et al
    A novel resistance gene, lnu(H), conferring resistance to lincosamides in Riemerella anatipestifer CH-2.
    Int J Antimicrob Agents. 2018;51:136-139.
    PubMed     Abstract available


  281. SEIFERT H, Stefanik D, Sutcliffe JA, Higgins PG, et al
    In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;51:62-64.
    PubMed     Abstract available


  282. VARDAKAS KZ, Voulgaris GL, Samonis G, Falagas ME, et al
    Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:1-9.
    PubMed     Abstract available


  283. PELLON A, Ramirez-Garcia A, Buldain I, Antoran A, et al
    Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?
    Int J Antimicrob Agents. 2018;51:10-15.
    PubMed     Abstract available


  284. VIEL A, Henri J, Perrin-Guyomard A, Laroche J, et al
    Lack of experimental evidence to support mcr-1-positive Escherichia coli strain selection during oral administration of colistin at recommended and higher dose given by gavage in weaned piglets.
    Int J Antimicrob Agents. 2018;51:128-131.
    PubMed     Abstract available


  285. PEETERS LEJ, Croubels S, Rasschaert G, Imberechts H, et al
    Effect of residual doxycycline concentrations on resistance selection and transfer in porcine commensal Escherichia coli.
    Int J Antimicrob Agents. 2018;51:123-127.
    PubMed     Abstract available


  286. FUKUDA A, Sato T, Shinagawa M, Takahashi S, et al
    High prevalence of mcr-1, mcr-3 and mcr-5 in Escherichia coli derived from diseased pigs in Japan.
    Int J Antimicrob Agents. 2018;51:163-164.
    PubMed    


    December 2017
  287. WI YM, Greenwood-Quaintance KE, Brinkman CL, Lee JYH, et al
    Rifampin resistance in staphylococcus epidermidis: molecular characterization and fitness cost of rpoB mutations.
    Int J Antimicrob Agents. 2017 Dec 26. pii: S0924-8579(17)30453.
    PubMed     Abstract available


  288. VARGAS-ALZATE CA, Higuita-Gutierrez LF, Lopez Lopez L, Cienfuegos Gallet AV, et al
    High excess costs of infections caused by carbapenem-resistant gram-negative bacilli in an endemic region.
    Int J Antimicrob Agents. 2017 Dec 22. pii: S0924-8579(17)30446.
    PubMed     Abstract available


  289. DIEZ-AGUILAR M, Conejo MC, Morosini MI, Palop NT, et al
    Susceptibility testing and detection of beta-lactam resistance mechanisms in enterobacteriaceae: a multicentre national proficiency study.
    Int J Antimicrob Agents. 2017 Dec 21. pii: S0924-8579(17)30442.
    PubMed     Abstract available


  290. CHUSRI S, Sakarunchai I, Kositpantawong N, Panthuwong S, et al
    Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017 Dec 11. pii: S0924-8579(17)30436.
    PubMed     Abstract available


    November 2017
  291. BROWN-JAQUE M, Calero-Caceres W, Espinal P, Rodriguez-Navarro J, et al
    Antibiotic resistance genes in phage particles isolated from human feces and induced from clinical bacterial isolates.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30431.
    PubMed     Abstract available


  292. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant klebsiella pneumoniae from vietnam.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30429.
    PubMed     Abstract available


  293. FREITAS AR, Novais C, Duarte B, Pereira AP, et al
    High rates of colonization by ampicillin-resistant enterococci in residents at long-term care facilities in Porto, Portugal.
    Int J Antimicrob Agents. 2017 Nov 23. pii: S0924-8579(17)30418.
    PubMed     Abstract available


  294. LI W, Liu JH, Zhang XF, Wang J, et al
    Emergence of methicillin-resistant staphylococcus aureus ST398 in pigs in china.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30386.
    PubMed    


  295. YEON PS, Jung LE, Tark K, Nae YS, et al
    Early administration of appropriate antimicrobial agent to improve the outcome of carbapenem resistant acinetobacter baumannii complex bacteremic pneumonia.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30391.
    PubMed     Abstract available


    October 2017
  296. IDELEVICH EA, Hoy M, Knaack D, Gorlich D, et al
    Direct determination of carbapenem-resistant enterobacteriaceae and pseudomonas aeruginosa from positive blood cultures using laser scattering technology.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30373.
    PubMed     Abstract available


  297. SOBKE A, Makarewicz O, Baier M, Bar C, et al
    Empiric treatment of lower urinary tract infections in the face of spreading multi-drug resistance: in vitro study of nitroxoline effectiveness.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30374.
    PubMed     Abstract available


    September 2017
  298. CAMPOS J, Mourao J, Silveira L, Saraiva M, et al
    Imported poultry meat as a source of extended-spectrum cephalosporin-resistant CMY-2-producing salmonella heidelberg and s. minnesota in european union, 2014-2015.
    Int J Antimicrob Agents. 2017 Sep 14. pii: S0924-8579(17)30346.
    PubMed     Abstract available


    August 2017
  299. GIANNELLA M, Trecarichi EM, Giacobbe DR, De FG, et al
    Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection.
    Int J Antimicrob Agents. 2017 Aug 22. pii: S0924-8579(17)30311.
    PubMed     Abstract available


  300. GUNATHILAKA GU, Tahlan V, Mafiz A, Polur M, et al
    Phage in urban wastewater have the potential to disseminate antibiotic resistance.
    Int J Antimicrob Agents. 2017 Aug 10. pii: S0924-8579(17)30305.
    PubMed     Abstract available


    July 2017
  301. LOPEZ-CAUSAPE C, de Dios-Caballero J, Cobo M, Escribano A, et al
    Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    Int J Antimicrob Agents. 2017 Jul 20. pii: S0924-8579(17)30284.
    PubMed     Abstract available


  302. ZHAO L, Liu A, Li R, Zhao S, et al
    Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Int J Antimicrob Agents. 2017 Jul 17. pii: S0924-8579(17)30214.
    PubMed     Abstract available


  303. BOUZID F, Astier H, Osman DA, Javelle E, et al
    Extended spectrum of antibiotic susceptibility for tuberculosis, djibouti.
    Int J Antimicrob Agents. 2017 Jul 12. pii: S0924-8579(17)30282.
    PubMed     Abstract available


  304. HOLZKNECHT BJ, Pinholt M, Gumpert H, Hammerum AM, et al
    Genetic characterization confirms sporadic occurrence of vancomycin-resistant Enterococcus faecalis in Copenhagen, Denmark.
    Int J Antimicrob Agents. 2017 Jul 11. pii: S0924-8579(17)30262.
    PubMed    


  305. BERNABE KJ, Langendorf C, Ford N, Ronat JB, et al
    Antibiotic resistance in West Africa: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Jul 10. pii: S0924-8579(17)30274.
    PubMed     Abstract available


  306. SUTERA V, Hoarau G, Renesto P, Caspar Y, et al
    In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in francisella tularensis, including in tularaemia patients with treatment failure.
    Int J Antimicrob Agents. 2017 Jul 6. pii: S0924-8579(17)30251.
    PubMed     Abstract available


  307. WHITE BP, Stover KR, Barber KE, Galloway RC, et al
    Mechanisms of Fosfomycin Resistance in Carbapenem-Resistant Enterobacter spp.
    Int J Antimicrob Agents. 2017 Jul 5. pii: S0924-8579(17)30203.
    PubMed     Abstract available


  308. LEE MR, Chien JY, Huang YT, Liao CH, et al
    Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Int J Antimicrob Agents. 2017;50:35-40.
    PubMed     Abstract available


  309. SPARHAM SJ, Kwong JC, Valcanis M, Easton M, et al
    Emergence of multidrug resistance in locally-acquired human infections with Salmonella Typhimurium in Australia owing to a new clade harbouring blaCTX-M-9.
    Int J Antimicrob Agents. 2017;50:101-105.
    PubMed     Abstract available


    June 2017
  310. CLAEYS KC, Zasowski EJ, Lagnf AM, Levine DP, et al
    Novel Application of Published Risk Factors for Methicillin-Resistant S. aureus in Acute Bacterial Skin and Skin Structure Infections.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30226.
    PubMed     Abstract available


  311. CHIEN JY, Yu CJ, Hsueh PR
    High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30207.
    PubMed     Abstract available


  312. SHAH KJ, Cherabuddi K, Shultz J, Borgert S, et al
    Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin resistant enterococcus spp (VRE): a single-center university hospital experience.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30218.
    PubMed     Abstract available


  313. FERLOV-SCHWENSEN SA, Sydenham TV, Hansen KC, Hoegh SV, et al
    Prevalences of antimicrobial resistance and the cfiA resistance gene in danish bacteroides fragilis group isolates since 1973.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30198.
    PubMed     Abstract available


  314. KELLY AM, Mathema B, Larson EL
    Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.
    Int J Antimicrob Agents. 2017 Jun 21. pii: S0924-8579(17)30192.
    PubMed     Abstract available


  315. SORANOGLOU V, Galanopoulos I, Giamarellos-Bourboulis EJ, Papalois A, et al
    Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30175.
    PubMed     Abstract available


  316. MOROZUMI M, Okada T, Tajima T, Ubukata K, et al
    Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30174.
    PubMed     Abstract available


  317. LI QJ, Jiao WW, Yin QQ, Li YJ, et al
    Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.
    Int J Antimicrob Agents. 2017;49:757-762.
    PubMed     Abstract available


  318. DAHDOUH E, Gomez-Gil R, Sanz S, Gonzalez-Zorn B, et al
    A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017;49:727-733.
    PubMed     Abstract available


  319. WI YM, Choi JY, Lee JY, Kang CI, et al
    Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Int J Antimicrob Agents. 2017;49:767-769.
    PubMed     Abstract available


  320. LIANG Q, Yin Z, Zhao Y, Liang L, et al
    Sequencing and comparative genomics analysis of the IncHI2 plasmids pT5282-mphA and p112298-catA and the IncHI5 plasmid pYNKP001-dfrA.
    Int J Antimicrob Agents. 2017;49:709-718.
    PubMed     Abstract available


    May 2017
  321. LOPEZ-DIAZ MC, Rios E, Rodriguez-Avial I, Simaluiza RJ, et al
    In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30172.
    PubMed     Abstract available


  322. BOURDELLON L, Thilly N, Fougnot S, Pulcini C, et al
    Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by french general practitioners in urinary tract infections: a randomised controlled case-vignette study.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30173.
    PubMed     Abstract available


  323. JAILLARD M, van Belkum A, Cady KC, Creely D, et al
    Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2017 May 26. pii: S0924-8579(17)30163.
    PubMed     Abstract available


  324. DUPIEUX C, Kolenda C, Larsen AR, Pichon B, et al
    Variable performance of four commercial chromogenic media for detection of methicillin-resistant Staphylococcus aureus isolates harbouring mecC.
    Int J Antimicrob Agents. 2017 May 23. pii: S0924-8579(17)30166.
    PubMed     Abstract available


  325. QIN X, Tran BG, Kim MJ, Wang L, et al
    A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Int J Antimicrob Agents. 2017;49:579-588.
    PubMed     Abstract available


  326. BROUQUI P, Quenard F, Drancourt M
    Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    Int J Antimicrob Agents. 2017;49:554-557.
    PubMed     Abstract available


  327. CAI X, Yang Z, Dai J, Chen K, et al
    Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Int J Antimicrob Agents. 2017;49:609-616.
    PubMed     Abstract available


  328. JEANNOT K, Bolard A, Plesiat P
    Resistance to polymyxins in Gram-negative organisms.
    Int J Antimicrob Agents. 2017;49:526-535.
    PubMed     Abstract available


  329. ZAYYAD H, Eliakim-Raz N, Leibovici L, Paul M, et al
    Revival of old antibiotics: needs, the state of evidence and expectations.
    Int J Antimicrob Agents. 2017;49:536-541.
    PubMed     Abstract available


  330. KAYE KS, Gales AC, Dubourg G
    Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes.
    Int J Antimicrob Agents. 2017;49:542-548.
    PubMed     Abstract available


  331. DUBOURG G, Abat C, Raoult D
    Why new antibiotics are not obviously useful now.
    Int J Antimicrob Agents. 2017;49:549-553.
    PubMed     Abstract available


    April 2017
  332. BI W, Li B, Song J, Hong Y, et al
    Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum beta-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Int J Antimicrob Agents. 2017 Apr 26. pii: S0924-8579(17)30135.
    PubMed     Abstract available


  333. CHANG YT, Coombs G, Ling T, Balaji V, et al
    Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013.
    Int J Antimicrob Agents. 2017 Apr 20. pii: S0924-8579(17)30121.
    PubMed     Abstract available


  334. KRAPP F, Grant JL, Sutton SH, Ozer EA, et al
    Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Int J Antimicrob Agents. 2017 Apr 4. pii: S0924-8579(17)30105.
    PubMed     Abstract available


  335. BI Z, Berglund B, Sun Q, Nilsson M, et al
    Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.
    Int J Antimicrob Agents. 2017;49:493-497.
    PubMed     Abstract available


  336. MORALES-BARROSO I, Lopez-Cerero L, Molina J, Bellido M, et al
    Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Int J Antimicrob Agents. 2017;49:498-502.
    PubMed     Abstract available


    March 2017
  337. SYDENHAM TV, Jensen BH, Petersen AM, Krogfelt KA, et al
    Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Int J Antimicrob Agents. 2017 Mar 31. pii: S0924-8579(17)30097.
    PubMed     Abstract available


  338. FLOKAS ME, Karageorgos SA, Detsis M, Alevizakos M, et al
    Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Mar 20. pii: S0924-8579(17)30086.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: